Close Menu

NEW YORK — The US Food and Drug Administration on Wednesday issued Emergency Use Authorizations for three SARS-CoV-2 tests from Quest Diagnostics that use nasal swab self-collection devices.

Quest's PF SARS-CoV-2 Assay is performed using Hologic's Panther Fusion SARS-CoV-2 RT-PCR-based test, its RC SARS-CoV-2 Assay is performed using Roche's automated Cobas SARS-CoV-2 RT-PCR test, and its HA SARS-CoV-2 Assay is performed using Hologic's Aptima SARS-CoV-2 test.

All three tests are RT-PCR-based and have previously received EUA from the FDA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.